VIRANATIVE
DEAD

Serial Number

78089680

Owner

Viragen Incorporated

Attorney

John C. Eisenhart

Filing Date

Oct 23, 2001

Add to watchlist:

No watchlists yet
View on USPTO

VIRANATIVE Trademark

Serial Number: 78089680 • Registration: 2956856

VIRANATIVE is a trademark filed by Viragen Incorporated on October 23, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Viragen Incorporated (2 trademarks)

865 SW 78th Avenue, Suite 100
Plantation, FL 33324

Entity Type: 03

VIRANATIVE AB (2 trademarks)

P.O. BOX 7979
SE-90719 UMEA , SE

Entity Type: 03

VIRAGEN INTERNATIONAL INC.

865 SW 78TH AVENUE
PLANTATION, FL 33324

Entity Type: 03

Trademark Details

Filing Date

October 23, 2001

Registration Date

May 31, 2005

Published for Opposition

March 8, 2005

Cancellation Date

September 28, 2012

Goods & Services

Apparatus for carrying out assays, namely, chromatographs, electrophoresis apparatus not for medical purposes, laboratory equipment, namely,spectroscopes, microarrays; apparatus for scientific use, namely, bioreactors;apparatus for research purposes, namely, chromatographs, electrophoresis apparatus not for medical purposes, laboratory equipment, namely,spectroscopes, microarrays; diagnostic apparatus for scientific use, namely,chromatographs, electrophoresis apparatus not for medical purposes, laboratory equipment, namely, spectroscopes, microarrays; diagnostic testing apparatus,namely, chromatographs, electrophoresis apparatus not for medical purposes,laboratory equipment, namely, spectroscopes, and microarrays

Biotechnological preparations for medical use, in the nature of interferons, antibodies; biotechnological preparations for veterinary use, in the nature of interferons, antibodies; chemical or biochemical products for medical or veterinary purposes, in the nature of interferons, antibodies; clinical diagnostic reagents; medical and veterinary reagents for medical laboratory use; drugs for medical purposes, namely, drugs for therapeutic purposes for the treatment of anti-viral oncological and autoimmune disease; bioactive substances obtained from animals or by synthesis for medical use, namely, interferons, antibodies; biological substances for medical use, namely, interferons, antibodies

Chemical or biochemical products for research purposes, namely, interferons, antibodies; chemicals or biochemicals for biotechnological research, namely, interferons, antibodies; chemicals or biochemicals for use in scientific research, namely, interferons, antibodies; diagnostic preparations, for scientific or research use in the field of immunology, namely, interferons, antibodies; reagents for in vitro or in vivo use for scientific or research use in the field of immunology, namely, interferons, antibodies; chemicals or biochemicals for use in the manufacture of drugs, namely, interferons, antibodies; biological preparations for laboratory purposes or for scientific purposes, namely, interferons; substances produced by chemical engineering, for scientific or research use in the field of immunology, namely, interferons, antibodies

Biotechnological research; scientific research; product safety and efficiency testing services for medical, veterinary and scientific research drugs; medical research; product development consultation services for dental, medical and scientific products; consultation services related to the design of consumer product safety programs; consultation services related to regulatory procedures and requirements for scientific, medical and veterinary products

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 28, 2012 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 10, 2008 TCCA
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 21, 2006 ERRR
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 13, 2006 COC.
ASSIGNED TO PARALEGAL
Oct 24, 2005 PLGL
SEC 7 REQUEST FILED
Jul 6, 2005 AMD7
PAPER RECEIVED
Jul 6, 2005 MAIL
REGISTERED-PRINCIPAL REGISTER
May 31, 2005 R.PR
PUBLISHED FOR OPPOSITION
Mar 8, 2005 PUBO
NOTICE OF PUBLICATION
Feb 16, 2005 NPUB
PAPER RECEIVED
Feb 2, 2005 MAIL
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 10, 2004 PREV
ASSIGNED TO LIE
Nov 5, 2004 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2004 CNSA
PAPER RECEIVED
Jun 10, 2004 MAIL
LETTER OF SUSPENSION MAILED
Apr 19, 2004 CNSL
EXAMINERS AMENDMENT MAILED
Apr 2, 2004 CNEA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2004 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 4, 2004 CRFA
PAPER RECEIVED
Mar 4, 2004 MAIL
NON-FINAL ACTION MAILED
Jan 8, 2004 CNRT
CASE FILE IN TICRS
Aug 31, 2003 CFIT
Sec. 1(B) CLAIM DELETED
Aug 7, 2003 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2003 CRFA
PAPER RECEIVED
Aug 7, 2003 MAIL
INQUIRY AS TO SUSPENSION MAILED
Jul 11, 2003 CNSI
LETTER OF SUSPENSION MAILED
Dec 4, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2002 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 23, 2002 CRFA
PAPER RECEIVED
Jul 23, 2002 MAIL
LETTER OF SUSPENSION MAILED
Jun 27, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2002 CRFA
NON-FINAL ACTION MAILED
Jan 29, 2002 CNRT
ASSIGNED TO EXAMINER
Jan 17, 2002 DOCK